{"Name":"Heron Therapeutics","perma":"heron-therapeutics","BasicInfo":{"funded":"1987-01-01","isClosed":false,"closed":null,"short":"Heron Therapeutics, Inc. (NASDAQ: HRTX) is a specialty pharmaceutical company developing products using its proprietary"},"FundingRounds":[{"funding_type":"venture","series":null,"announcedDate":"2011-07-11","moneyRaised":24000001}],"Acquisitions":[],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"HRTX","shares":null,"date":"2013-01-11","openPrice":null,"moneyRaised":null,"valuation":null},"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"CEO & Director","started":"2014-01-01","ended":null,"firstName":"Barry","lastName":"Quart"},{"title":"SVP & CMO","started":"2014-01-01","ended":null,"firstName":"Mark","lastName":"Gelder"},{"title":"VP, Finance & CFO","started":"2014-01-01","ended":null,"firstName":"Brian","lastName":"Drazba"}],"PastTeam":[]}
